Galapagos N.V.

Galapagos N.V.verified

GLPGF

Price:

$31.29

Market Cap:

$1.78B

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The company's pipeline products also comprise GLPG1972 that has completed Phase 2b trial for treating osteoarthritis; Toledo molecules, including GLPG3970, GLPG4399, and GLPG4876 for inflammation; and GLPG4716 and Ziritaxestat to treat idiopathic pulmonary fib...[Read more]

Industry

Biotechnology

IPO Date

2009-08-03

Stock Exchange

OTC

Ticker

GLPGF

The ROE as of December 2025 (TTM) for Galapagos N.V. (GLPGF) is -10.20%

According to Galapagos N.V.’s latest financial reports and current stock price. The company's current ROE is -10.20%. This represents a change of 289.55% compared to the average of -2.62% of the last 4 quarters.

Galapagos N.V. (GLPGF) Historical ROE (quarterly & annually)

How has GLPGF ROE performed in the past?

The mean historical ROE of Galapagos N.V. over the last ten years is -4.88%. The current -10.20% ROE has changed 108.76% with respect to the historical average. Over the past ten years (40 quarters), GLPGF's ROE was at its highest in in the September 2019 quarter at 14.25%. The ROE was at its lowest in in the December 2015 quarter at -15.62%.

Quarterly (TTM)
Annual

Average

-4.88%

Median

-3.58%

Minimum

-32.44%

Maximum

7.57%

Galapagos N.V. (GLPGF) ROE by Quarter and Year

Discovering the peaks and valleys of Galapagos N.V. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 81.88%

Maximum Annual ROE = 7.57%

Minimum Annual Increase = -323.51%

Minimum Annual ROE = -32.44%

Quarterly (TTM)
Annual
YearROEChange
20242.56%-66.23%
20237.57%-187.75%
2022-8.63%81.88%
2021-4.74%-59.26%
2020-11.65%-323.51%
20195.21%-316.25%
2018-2.41%-78.92%
2017-11.43%-260.60%
20167.12%-121.94%
2015-32.44%-301.36%

Galapagos N.V. (GLPGF) Average ROE

How has GLPGF ROE performed in the past?

The current ROE of Galapagos N.V. (GLPGF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

0.50%

5-year avg

-2.98%

10-year avg

-4.88%

Galapagos N.V. (GLPGF) ROE vs. Peers

How is GLPGF’s ROE compared to its peers?

Galapagos N.V.’s ROE is less than Bavarian Nordic A/S (12.45%), greater than Ryman Healthcare Limited (-10.21%), less than Bavarian Nordic A/S (12.45%), less than Telix Pharmaceuticals Limited (7.02%), less than Gedeon Richter PLC (17.11%), less than Shandong Weigao Group Medical Polymer Company Limited (8.22%), less than MediPal Holdings Corporation (6.59%), less than Shandong Weigao Group Medical Polymer Company Limited (8.22%), less than Ansell Limited (5.79%), greater than Oxford Nanopore Technologies plc (-19.36%),

Build a custom stock screener for Galapagos N.V. (GLPGF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galapagos N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Galapagos N.V. (GLPGF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Galapagos N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Galapagos N.V.'s ROE?

How is the ROE calculated for Galapagos N.V. (GLPGF)?

What is the highest ROE for Galapagos N.V. (GLPGF)?

What is the 3-year average ROE for Galapagos N.V. (GLPGF)?

What is the 5-year average ROE for Galapagos N.V. (GLPGF)?

How does the current ROE for Galapagos N.V. (GLPGF) compare to its historical average?